Encouraging findings need to be confirmed in a larger trial, experts say
Early signs of trouble seen in gene carriers
And the higher and longer the exposure, the bigger the threat, study finds
They could help manage threats such as deep-vein thrombosis
Study upholds the use of these devices to replace bare metal stents
Excess weight and inactivity are the key reasons, study says
Online tool scores threat based on health, habits and lifestyle
Study results could change standard practice, researchers say
Common drug outperformed psychotherapy in trial
The syndrome includes factors such as obesity and high blood pressure
Treatment should be tailored to individual patients, experts say
They suffer first attack at 53 years, compared to 58.8 years for westerners
Medicines for diabetes and cholesterol cut risk factors for heart attacks, study suggests
The tip of chromosomes might be useful diagnostic tool for men, study suggests
Program also recognizes companies that foster healthy work environments
CT scan detected potentially fatal subepicardial aneurysm
Goal is to reduce blood-clot risk in heart patients getting drug-coated devices
But study was small and the compound has downsides, experts caution
But some specialists say study findings won't have immediate impact on practice
Despite rising diagnoses, better care means patients enjoying better quality of life, study finds
It wipes out the valuable effects of antioxidants, study finds
Doctors need to weigh the risk of stroke vs. bleeding before prescribing warfarin
'Start!' asks employers to encourage regular exercise for workers
New test detects who will benefit from the costly device, study finds
The blood fats are a major cause of artery-clogging illness
Pergolide and cabergoline have same effect as now-banned Fen-phen, studies find
But researchers think the approach could one day pay dividends
Latest U.S. statistics suggest obesity, smoking are largely to blame
Researcher says newer measures not ready for primetime
Cardiovascular, kidney risks mean Trasylol should only be used in special circumstances
Study finds it bears little relation to actual patient outcomes
Lifestyle changes more likely to prevent second heart attack, study finds
Despite death of Pfizer drug, researchers say investigation of concept should continue
But all patients at heightened risk of blood clots, FDA panel concludes
But the devices may be the cause of blood clots, FDA panel notes
Dutch study finds chance for incident increased at least 30 percent
Safety concerns are raising doubts about the artery-opening devices
While they offer benefits, they may not be appropriate for all heart patients, FDA says
Heart patients with such stents face higher sudden-death risk, cardiologists report.
They're more likely to lack medication and endure delays in care, study finds
Pfizer compound sought to raise 'good' cholesterol, but trial revealed unacceptable death rate
Despite clotting dangers, the devices are still the best option, some cardiologists say
But levels of procyanidins aren't the same in all wines, study says
But the drugs didn't reduce threat of coronary heart disease or overall death
Their odds of second attack are higher than for those with prior history of depression, study finds
Tiny implanted devices are keeping one Texas family alive
Genetics could alter the cells' sodium channel function, study finds
Bivalirudin cut down on bleeding episodes, researchers found
The finding brings experts a step closer to stem cell-based treatments
Widely used 'risk score' underestimates dangers to end-stage patients, study finds